Showing results (41-50 of 82) with videos related to

Sort By:
Pageof 9
Scientific Reports|November 24, 2017
Nanoparticle core stability and surface functionalization drive the mTOR signaling pathway in hepatocellular cell linesMariia Lunova, Andrey Prokhorov, Milan Jirsa, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro|October 15, 2016
Modulation of collective cell behaviour by geometrical constraintsMariia Lunova, Vitalii Zablotskii, Nora M Dempsey, et al.
Gastroenterology|July 14, 2005
Dual hereditary jaundice: simultaneous occurrence of mutations causing Gilbert's and Dubin-Johnson syndromeDita Cebecauerova, Tomas Jirasek, Lucie Budisova, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 3, 2004
Indel in the FIC1/ATP8B1 gene-a novel rare type of mutation associated with benign recurrent intrahepatic cholestasisMilan Jirsa, Dita Cebecauerova, Lucie Budisova, et al.
Acta Biomaterialia|May 6, 2022
The interactions between DNA nanostructures and cells: A critical overview from a cell biology perspectiveAdam Frtús, Barbora Smolková, Mariia Uzhytchak, et al.
The Canadian Journal of Cardiology|October 30, 2016
Successful Treatment of Iron-Overload Cardiomyopathy in Hereditary Hemochromatosis With Deferoxamine and DeferiproneLydie Tauchenová, Barbora Křížová, Miloš Kubánek, et al.
World Journal of Gastroenterology|May 20, 2015
Relevance of low viral load in haemodialysed patients with chronic hepatitis C virus infectionJan Sperl, Sona Frankova, Renata Senkerikova, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 6, 2019
IL28B rs12979860 T allele protects against CMV disease in liver transplant recipients in the post-prophylaxis and late periodKlara Chmelova, Sona Frankova, Milan Jirsa, et al.
Human Mutation|February 4, 2010
Disruption of OTC promoter-enhancer interaction in a patient with symptoms of ornithine carbamoyltransferase deficiencyOndrej Luksan, Milan Jirsa, Jitka Eberova, et al.
Pageof 9